This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
C$60.65
Share price
0.00%
Change (1 day)
117.02%
Change (1 year)
Categories
Market capitalization of Albireo Pharma (ALBO)
Last known market cap: C$1.25 Billion
On May 5, 2023 Albireo Pharma had a market cap of C$1.25 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Albireo Pharma from 2007 to 2023
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2023 | C$1.21 B | 100.12% |
| 2022 | C$0.60 B | 5.99% |
| 2021 | C$0.57 B | -37.33% |
| 2020 | C$0.91 B | 115.9% |
| 2019 | C$0.42 B | 5.83% |
| 2018 | C$0.39 B | 39.64% |
| 2017 | C$0.28 B | 91.04% |
| 2016 | C$0.14 B | 391.79% |
| 2015 | C$30.48 M | -15.78% |
| 2014 | C$36.19 M | -29.22% |
| 2013 | C$51.14 M | 54.36% |
| 2012 | C$33.12 M | 37.93% |
| 2011 | C$24.01 M | -50.33% |
| 2010 | C$48.35 M | -55.66% |
| 2009 | C$0.10 B | -21.52% |
| 2008 | C$0.13 B | -70.43% |
| 2007 | C$0.47 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | C$1.33 B | 6.44% | 🇺🇸 USA |